FlashPlate Scintillation Proximity Assays for Characterization and Screening of DNA Polymerase, Primase, and Helicase Activities
Overview
Authors
Affiliations
DNA replication proteins represent a class of extremely well-established anti-infective drug targets for which improvements in assay technology are required in order to support enzyme characterization, HTS, and structure-activity relationship studies. Replication proteins are conventionally assayed using precipitation/filtration or gel-based techniques, and are not yet all suitable for conversion into homogeneous fluorescence-based formats. We have therefore developed radiometric assays for these enzymes based upon FlashPlate technology that can be applied to a wide range of targets using a common set of reagents. This approach has allowed the rapid characterization of DNA polymerase, DNA primase, and DNA helicase activities. The resultant 96-/384-well microplate assays are suitable for primary HTS, hit selectivity determination, and/or elucidating the mechanism of action of inhibitors. In all cases, biotinylated DNA oligonucleotide substrates were tethered to streptavidin-coated scintillant-embedded FlashPlate wells. Various adaptations were employed for each enzyme activity. For DNA polymerase, a short complementary oligonucleotide primer was annealed to the longer tethered oligonucleotide, and polymerization was measured by incorporation of [(3)H]-dNTPs onto the growing primer 3' end. For DNA primase, direct synthesis of short oligoribonucleotides complementary to the tethered DNA strand was measured by incorporation of [(3)H]-rNTPs or by subsequent polymerase extension with [(3)H]-dNTPs from unlabeled primers. For DNA helicase, unwinding of a [(33)P]-labeled oligonucleotide complementary to the tethered oligonucleotide was measured. This robust and flexible system has a number of substantial advantages over conventional assay techniques for this difficult class of enzymes.
Li B, Pai R, Aiello D, Di M, Barnes M, Peet N Bioorg Med Chem Lett. 2013; 23(12):3481-6.
PMID: 23664213 PMC: 3691018. DOI: 10.1016/j.bmcl.2013.04.055.
Discovering new medicines targeting helicases: challenges and recent progress.
Shadrick W, Ndjomou J, Kolli R, Mukherjee S, Hanson A, Frick D J Biomol Screen. 2013; 18(7):761-81.
PMID: 23536547 PMC: 4427233. DOI: 10.1177/1087057113482586.
Li B, Pai R, Di M, Aiello D, Barnes M, Butler M J Med Chem. 2012; 55(24):10896-908.
PMID: 23231076 PMC: 3531573. DOI: 10.1021/jm300922h.
Robinson A, Causer R, Dixon N Curr Drug Targets. 2011; 13(3):352-72.
PMID: 22206257 PMC: 3290774. DOI: 10.2174/138945012799424598.
Aiello D, Barnes M, Biswas E, Biswas S, Gu S, Williams J Bioorg Med Chem. 2009; 17(13):4466-76.
PMID: 19477652 PMC: 2776654. DOI: 10.1016/j.bmc.2009.05.014.